KEGG: spo:SPAC27E2.04c
The meiotically up-regulated gene 155 protein (mug155) is a 187-amino acid protein encoded by the SPAC27E2.04c gene locus in Schizosaccharomyces pombe . To properly investigate its cellular functions, researchers should implement a systematic approach combining genetic knockout studies, fluorescent tagging for localization analysis, and transcriptomic profiling during meiotic progression.
While definitive functions remain under investigation, methodological approaches should include:
Creation of mug155Δ strains to assess phenotypic consequences during meiosis
Temporal expression analysis through synchronized meiotic cultures
Subcellular fractionation coupled with western blotting
Co-immunoprecipitation to identify physical interaction partners
Current research suggests involvement in meiotic processes based on its classification as a meiotically up-regulated gene, though specific molecular mechanisms require further characterization.
To validate and extend our understanding of mug155's meiotic upregulation, researchers should implement the following methodological approaches:
Quantitative RT-PCR across synchronized meiotic time points using the following experimental design:
Culture synchronization using nitrogen starvation protocols
Sample collection at 0, 1, 2, 4, 6, 8, and 10 hours after meiotic induction
RNA extraction with hot phenol method optimized for yeast
cDNA synthesis with oligo-dT and random hexamer primers
qPCR with mug155-specific primers normalized to constitutive genes (act1, cdc2)
RNA-seq analysis comparing vegetative growth vs. meiotic timepoints
Promoter analysis using:
In silico identification of meiosis-specific transcription factor binding sites
Reporter gene constructs with wild-type and mutated promoter variants
ChIP-seq for meiotic transcription factors at the mug155 locus
The experimental design should include appropriate controls and replication as specified in experimental design principles , with a minimum of three biological replicates and two technical replicates per condition.
For comprehensive identification of functional domains and motifs in mug155, researchers should employ a systematic analytical workflow:
Primary Sequence Analysis:
PROSITE scanning for consensus motifs
PRINTS and BLOCKS searches for conserved sequence patterns
Signal peptide prediction using SignalP
Post-translational modification prediction (NetPhos, NetOGlyc, NetNGlyc)
Structural Analysis:
Secondary structure prediction (JPred, PSIPRED)
Disorder prediction (DISOPRED, IUPred)
Coiled-coil prediction (COILS, Paircoil)
Transmembrane region analysis (TMHMM, Phobius)
Functional Motif Identification:
Linear motif scanning (ELM database)
DNA/RNA binding prediction (BindN, RNABindR)
Nuclear localization/export signal identification (NLStradamus, NetNES)
The sequence "KIRCRLKKKFI" (positions 65-75) suggests a potential nuclear localization signal that warrants experimental validation through mutagenesis and localization studies.
To comprehensively profile mug155 expression throughout meiosis, researchers should implement a multi-faceted approach:
High-resolution temporal expression analysis:
Synchronized cultures using temperature-sensitive pat1-114 mutant
Sample collection at 15-minute intervals for the first 4 hours, then 30-minute intervals
Parallel assessment of known meiotic phase markers (rec8, mei4, spo6)
Protein-level quantification:
Western blotting with anti-mug155 antibodies or epitope-tagged mug155
Pulse-chase experiments to determine protein half-life
Fluorescent reporter fusions for live-cell imaging
Single-cell analysis:
smFISH (single-molecule fluorescence in situ hybridization) for mRNA detection
Flow cytometry of GFP-tagged mug155 to assess population heterogeneity
| Meiotic Phase | Time (h) | Expected Expression Pattern | Control Markers |
|---|---|---|---|
| Pre-meiotic S | 0-1 | Baseline measurement | mcm4, cdc18 |
| Prophase I | 1-2.5 | Early induction | rec8, rec12 |
| Metaphase I | 2.5-3 | Peak expression (hypothesized) | mei4, cdc13 |
| Anaphase I | 3-3.5 | Sustained expression | spo6 |
| Meiosis II | 3.5-5 | Potential second peak | sps4 |
| Sporulation | 5-8 | Downregulation | spo13, spo20 |
The experimental design should incorporate randomized block design with appropriate controls as outlined in experimental design principles , ensuring statistical validity of temporal expression patterns.
For comprehensive characterization of mug155 protein-protein interactions, researchers should implement a multi-technique approach:
Affinity Purification-Mass Spectrometry (AP-MS):
Yeast Two-Hybrid Screening:
Construction of mug155 bait fused to DNA-binding domain
Screening against S. pombe meiotic cDNA library
Validation of interactions through reverse Y2H
Analysis of interaction domains through truncation constructs
Proximity-Based Labeling:
BioID or TurboID fusion to mug155
In vivo biotin labeling during meiotic progression
Streptavidin pull-down and MS identification
Temporal mapping of interaction networks
Co-immunoprecipitation Validation:
Endogenous tagging of candidate interactors
Reciprocal co-IP experiments
Sequential IP to identify complex composition
Crosslinking IP for transient interactions
The experimental design should follow a completely randomized design with multiple biological replicates. Statistical analysis should employ appropriate filtering criteria to distinguish true interactors from background contaminants, with significance thresholds adjusted for multiple comparisons.
To elucidate mug155's functional contributions to meiosis, researchers should implement a comprehensive experimental strategy:
Genetic Approaches:
Generation of mug155 null, conditional, and separation-of-function mutants
Complementation with wild-type and mutant alleles
Synthetic genetic interaction screening with known meiotic factors
Construction of analog-sensitive alleles for acute inhibition
Cytological Analysis:
Immunofluorescence microscopy of meiotic chromosome structures
Live-cell imaging of fluorescently tagged mug155 with meiotic markers
Electron microscopy of synaptonemal complex formation
Super-resolution microscopy for precise localization
Biochemical Characterization:
In vitro reconstitution of mug155-containing complexes
Activity assays based on predicted biochemical functions
Chromatin association analysis through ChIP-seq
Post-translational modification profiling during meiotic progression
Phenotypic Assessment:
Quantification of meiotic progression timing
Measurement of recombination frequency and distribution
Analysis of chromosome segregation fidelity
Sporulation efficiency and spore viability determination
The experimental design should incorporate factorial approaches to test for potential genetic interactions, with replication and randomization principles applied as recommended in experimental design literature .
For comprehensive evolutionary analysis of mug155, researchers should implement a systematic bioinformatic pipeline:
Sequence-Based Homology Detection:
Position-Specific Iterative BLAST (PSI-BLAST) with graduated E-value thresholds
Profile Hidden Markov Model searches using HMMER
Sensitive fold-recognition methods (HHpred, PHYRE2)
Domain architecture analysis to identify partial homologs
Phylogenetic Analysis:
Multiple sequence alignment with MAFFT or T-Coffee
Alignment curation with Gblocks or TrimAl
Model selection using ProtTest
Maximum likelihood tree construction (RAxML, IQ-TREE)
Bayesian inference (MrBayes, PhyloBayes)
Synteny and Genomic Context Analysis:
Microsynteny mapping across fungal genomes
Analysis of conserved gene neighborhoods
Identification of orthologous genomic regions
Functional Divergence Assessment:
Site-specific evolutionary rate analysis
Prediction of functionally important residues
Molecular evolutionary analyses for positive selection
Ancestral sequence reconstruction
This methodological framework should be applied hierarchically, first within Schizosaccharomyces species, then expanding to other yeasts, fungi, and eventually eukaryotes, with appropriate statistical validation at each step.
For maximizing expression and solubility of recombinant mug155, researchers should systematically optimize the following parameters:
Expression System Selection:
Induction Parameters Optimization:
| Parameter | Variables to Test | Initial Recommendation |
|---|---|---|
| Temperature | 16°C, 25°C, 30°C, 37°C | 25°C |
| IPTG concentration | 0.1, 0.5, 1.0 mM | 0.5 mM |
| Induction duration | 3h, 6h, overnight | 6h |
| Media composition | LB, TB, 2xYT, M9 | TB |
| OD600 at induction | 0.4, 0.6, 0.8, 1.0 | 0.6 |
Solubility Enhancement Strategies:
Co-expression with chaperones (GroEL/GroES, DnaK/DnaJ)
Addition of solubility tags (MBP, SUMO, Trx)
Culture additives (5-10% glycerol, 0.1-1% glucose)
Low-temperature autoinduction
Harvest and Initial Processing:
Cell lysis optimization (sonication vs. French press vs. chemical lysis)
Solubility assessment in various buffers
Initial clarification through high-speed centrifugation (20,000 × g)
The experimental approach should follow a factorial design to identify interaction effects between variables , with a minimum of three biological replicates per condition. Expression levels should be quantified by SDS-PAGE densitometry and Western blotting, with protein solubility assessed by comparing supernatant vs. pellet fractions.
For optimal purification of His-tagged recombinant mug155, researchers should implement a multi-step chromatography protocol:
Primary Affinity Chromatography:
Secondary Purification:
Size Exclusion Chromatography (Superdex 75/200)
Ion Exchange Chromatography (Resource Q/S)
Hydrophobic Interaction Chromatography as needed
Quality Control Assessment:
Storage Optimization:
For reconstitution, researchers should dissolve lyophilized protein in deionized sterile water to a concentration of 0.1-1.0 mg/mL , followed by addition of glycerol to 50% final concentration for storage stability.
The purification strategy should be validated through activity assays appropriate to the protein's function, with yields and purity documented at each chromatographic step.
For rigorous investigation of mug155 function in vivo, researchers should adhere to these experimental design principles:
Genetic Manipulation Approaches:
Complete gene deletion (mug155Δ)
Conditional expression systems (nmt1 promoter series)
Auxin-inducible degron for rapid protein depletion
Site-directed mutagenesis of critical residues
Fluorescent protein tagging at N/C termini
Experimental Design Structure:
Phenotypic Characterization Matrix:
| Aspect | Methodologies | Quantitative Metrics |
|---|---|---|
| Meiotic progression | Time-lapse microscopy | Timing of phase transitions |
| Chromosome dynamics | Live-cell imaging | Bouquet formation, oscillation amplitude |
| Recombination | Genetic assays, Immunofluorescence | Crossover frequency, Rad51 foci count |
| Spore formation | Tetrad dissection | Spore viability, segregation patterns |
Statistical Analysis Framework:
To comprehensively characterize the molecular interactions of mug155, researchers should employ a complementary suite of biochemical assays:
Protein-Protein Interaction Assays:
Surface Plasmon Resonance (SPR):
Microscale Thermophoresis (MST):
Label mug155 with fluorescent dye
Titrate unlabeled interaction partners
Analyze thermophoretic mobility shifts
Suitable for weak and transient interactions
Isothermal Titration Calorimetry (ITC):
Direct measurement of binding thermodynamics
Determination of stoichiometry, binding affinity, enthalpy
No labeling or immobilization required
Protein-Nucleic Acid Interaction Assays:
Electrophoretic Mobility Shift Assay (EMSA):
Incubate recombinant mug155 with labeled DNA/RNA
Analyze mobility shifts on native PAGE
Perform competition assays with unlabeled nucleic acids
Fluorescence Anisotropy:
Use fluorescently labeled oligonucleotides
Titrate with increasing mug155 concentrations
Determine binding constants and specificity
Chromatin Immunoprecipitation (ChIP):
In vivo crosslinking of protein-DNA interactions
Immunoprecipitation with anti-mug155 antibodies
NGS or qPCR analysis of bound DNA sequences
Structural Characterization:
Hydrogen-Deuterium Exchange Mass Spectrometry (HDX-MS) to map interaction interfaces
Cross-linking Mass Spectrometry (XL-MS) to identify proximity relationships
Small-Angle X-ray Scattering (SAXS) for complex architecture
The experimental design should follow factorial approaches with appropriate randomization and replication , and include negative controls (BSA, unrelated proteins) and positive controls (known interaction partners if available).
For robust analysis of mug155 expression data, researchers should implement a comprehensive statistical framework:
Preprocessing and Quality Control:
RNA-seq data: Quality filtering, adapter trimming, alignment to S. pombe genome
qRT-PCR data: Assessment of primer efficiency, melt curve analysis
Outlier detection through robust statistical methods (Grubb's test, Cook's distance)
Normalization Strategies:
RNA-seq: RPKM/FPKM, TPM, or DESeq2 normalization
qRT-PCR: ΔΔCt method with validated reference genes (act1, cdc2)
Batch effect correction using ComBat or surrogate variable analysis
Statistical Testing Framework:
Experimental Design Considerations:
Visualization Approaches:
MA plots for differential expression
Clustered heatmaps for expression patterns
Principal Component Analysis for global variation
Gene Set Enrichment Analysis for functional interpretation
Statistical significance should be assessed at α=0.05 with appropriate multiple testing correction (Benjamini-Hochberg procedure), and biological significance should be evaluated through effect size measurements (log2 fold change ≥1).
When faced with contradictory findings about mug155 function, researchers should implement a systematic resolution strategy:
Methodological Reconciliation Approach:
Critical Comparison of Experimental Conditions:
Strain background differences (h+, h-, h90)
Culture conditions (media composition, temperature)
Induction methods (nitrogen starvation vs. temperature shift)
Timing of observations (synchronization quality)
Technical Validation Across Platforms:
Validate expression changes with orthogonal methods (RNA-seq + qRT-PCR + Western blot)
Confirm phenotypes with multiple assays (microscopy + biochemical tests)
Cross-validate protein interactions with different techniques (Y2H, co-IP, BioID)
Integrated Experimental Design:
Statistical Framework for Resolution:
Meta-analysis of multiple datasets
Bayesian analysis incorporating prior knowledge
Effect size calculation to assess biological significance
Equivalence testing to establish compatibility of findings
Mechanistic Investigation of Contradictions:
Generate testable hypotheses to explain contradictions
Identify potential context-dependent functions
Design experiments specifically targeting variable conditions
Develop computational models to reconcile disparate observations
The resolution strategy should follow principles of replication, randomization, and local control to ensure statistical validity, with emphasis on identifying interaction effects between experimental variables that may explain contradictory findings.
For comprehensive computational characterization of mug155, researchers should implement an integrated bioinformatic workflow:
This integrated pipeline leverages complementary approaches to enhance prediction accuracy. Results should be critically evaluated through confidence metrics and consensus approaches, with experimental validation of key predictions.
When designing experiments with recombinant mug155 protein, researchers should adhere to these comprehensive guidelines:
Pre-Experimental Planning:
Protein Specification:
Experimental Design Structure:
Handling and Storage Protocols:
Reconstitution Procedure:
Storage Guidelines:
Experimental Quality Control:
Protein Validation:
Activity Benchmarking:
Develop functional assays relevant to mug155's predicted activity
Establish dose-response relationships
Determine stability under experimental conditions
Data Collection and Analysis: